OTC Link
PROVECTUS BIOPHARMS
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | Q1 2026 | — | 0.00 | — | $0 | — | -1.14% | -6.29% | — |
| 2026-03-26 | Q4 2025 | — | 0.00 | — | $0 | — | +0.00% | +0.42% | +15.34% |
| 2025-11-13 | Q3 2025 |
| — |
| 0.00 |
| — |
| $0 |
| — |
| — |
| — |
| — |
| 2025-08-14 | Q2 2025 | — | 0.00 | — | $57,480 | — | -1.03% | -5.84% | -21.05% |
| 2025-03-27 | Q4 2024 | — | 0.00 | — | $14,332 | — | +0.20% | -0.30% | -18.50% |
| 2024-08-13 | Q2 2024 | — | 0.00 | — | $254,991 | — | +1.25% | +13.77% | +20.82% |
| 2024-05-14 | Q1 2024 | — | 0.00 | — | $238,072 | — | +0.00% | -2.21% | -21.31% |
| 2024-03-28 | Q4 2023 | — | 0.00 | — | $121,110 | — | — | — | — |
Showing last 8 quarters.